Ketone bodies for hemodynamic support in acute pulmonary embolism: a randomized, blinded, controlled animal study
Mads Dam Lyhne(Aarhus University Hospital), Roni Nielsen(Aarhus University), Kristoffer Berg‐Hansen(Aarhus University), Ebbe Boedtkjer(Aarhus University), Jacob Valentin Hansen(Aarhus University Hospital), Nigopan Gopalasingam(Aarhus University Hospital), Jacob Marthinsen Seefeldt(Aarhus University), Casper Homilius(Aarhus University), Oskar Kjærgaard Hørsdal(Aarhus University Hospital), Asger Andersen(Aarhus University), Simone Juel Dragsbæk(Aarhus University), Mark Stoltenberg Ellegaard(Aarhus University), Anders Kramer(Aarhus University Hospital)
Cited by 0
Related Papers
The Acidic Tumor Microenvironment as a Driver of Cancer
|Annual Review of Physiology|2019|1.2k
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
|European Journal of Heart Failure|2016|561
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
|Circulation|2019|526
Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
|Journal of the American Heart Association|2017|235
Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
|American Journal of Physiology-Heart and Circulatory Physiology|2010|165